In an enlightening segment on KTLA5, Dr. Christopher Davis, cardiologist and Chief Medical Officer of Liquivida, alongside Liquivida's Founder and President, Sam Tejada, delve into the new FDA approval of the weight loss drug Wegovy for heart disease prevention.

Discover the transformative journey of Sam Tejada, who personally experienced significant weight loss using injectables like Wegovy, and learn about the potential impact this approval might have on accessibility and the medical community's approach to treating heart disease and stroke.

Dr. Davis sheds light on the drug's mechanism, its safety profile, and the importance of considering individual patient needs. This discussion not only explores the groundbreaking approval but also emphasizes the crucial role of lifestyle changes in maintaining weight loss and overall health. Join us for an in-depth look at the future of weight management and cardiovascular disease prevention.

• Sam Tejada
Instagram: https://www.instagram.com/sammy_tejada/
Threads: https://www.threads.net/@sammy_tejada
LinkedIn: https://www.linkedin.com/in/samtejada
Twitter: https://twitter.com/SamaelTejada
TikTok: https://www.tiktok.com/@sammy_tejada
Facebook: https://www.facebook.com/samael.tejada
Website: https://samtejada.com
Podpage: https://podcast.samtejada.com

• Dr. Christopher Davis
LinkedIn: https://www.linkedin.com/in/christopher-davis-md-facc
Instagram: https://instagram.com/cjdavismd
Facebook: https://www.facebook.com/cjdavismd

Liquivida® is a Wellness Center that offers Nutrient and Vitamins IV Therapy, and Innovative Aesthetics and Weight-loss Solutions.

Follow us:
http://www.facebook.com/Liquivida
https://www.linkedin.com/company/liquivida/
http://www.instagram.com/Liquivida
http://www.twitter.com/LiquividaLounge

Learn more:
http://www.liquivida.com